Skip to main content
OpenTrials
Completed

NCT Number: NCT04955522

Multimodal Imaging Analysis of Spinal Tumors

In this study, we retrospectively analyzed the imaging data of spinal tumors to find out more imaging features of spinal tumors, in order to provide more accurate reference for the diagnosis of spinal tumors.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Peking University Third Hospital

Beijing, Beijing Municipality, 010, China

About this study

Bone tumors account for 1-2% of total body tumors, and spinal tumors only account for 6.5% of total body tumors. Because of the low incidence rate, the number of patients and the attention in this field are far lower than other tumors, so far, all the researches on spinal tumors are relatively lacking. Because the diagnosis of bone tumor needs the combination of clinical, imaging and pathological to make a more accurate diagnosis, so the imaging diagnosis of spinal tumor is very important. In this study, through retrospective analysis of a variety of imaging data of patients with spinal tumor, measurement and recording of spinal tumor image related parameters, and statistical analysis, in order to find out more imaging characteristics of patients with spinal tumor, more accurate diagnosis of lesions, and provide more help for clinical decision-making.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Complete and accurate clinical and pathological data are available;Imaging examination was performed in our hospital

Exclusion criteria

  • Patients with missing image data and unclear image

Treatment and study plan

radiomics

Diagnostic Test

Differential diagnosis of spinal myeloma and metastases by radiomics

Primary outcomes

  1. radiomics features

    Time frame: 2020.12.1-2020.12.25

    1409 radiomics features can be extracted from the images. Objective to search for the radiomics index which is helpful to the diagnosis of tumor.

Sponsors and collaborators

Lead sponsor

Peking University Third Hospital

Other

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Jul 8, 2021
Registry last updated
Jul 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.